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Ideal Practice Design
• Patients seen in person first
• Remote clinic with adequate technology, 
large, well-lit room
• Staff present to take history, vitals, and 
perform certain physical exam maneuvers
Relevance to SELECT
• VBPCC – telemedicine provides comfort, 
convenience, and savings for patients
• Health Systems – importance of 
understanding how reimbursement, 
licensing, and practice design influence 
patient access to care
Current perspectives on the role of telemedicine in the management of 
Parkinson’s disease
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Problem Statement
• Parkinson’s disease (PD) is a progressive 
neurological disorder
• The number of patients who receive 
specialty care continues to be limited
• The benefits of seeing a movement 
disorder specialist for management of PD 
have been well established
• Telemedicine has been suggested as a 
useful tool in addressing the problem of 
access to specialty care
• The literature suggests that using 
telemedicine to treat PD is
– Feasible and economically 
advantageous
– Associated with high satisfaction
– Comparable in quality to in-person 
care
This project will evaluate the advantages and 
disadvantages of telemedicine visits to patients 
with Parkinson’s disease and to their medical 
providers.
• The literature search strategy is illustrated 
by Figure 1
• Evidence was evaluated using the Joanna 
Briggs Institute Checklist1 for the 
randomized controlled trials, case series, 
and case reports
• The survey studies were evaluated using 
the Center for Evidence-Based Medicine 
checklist2. 
Advantages of Telemedicine
• Treating PD with telemedicine is feasible 
and economically advantageous
• High levels of interest and satisfaction exist 
with patients and providers
• Quality of care is comparable to in-person 
care based on objective measures
• May increase access to care
Limitations of Telemedicine
• Current research is limited by sample size, 
demographics, and risk of bias
• Current video technology may not be 
sufficient to detect necessary details
• Reimbursement for telemedicine visits 
remains limited
• Physicians are required to be licensed in 
the state where the patient is physically 
located
Background Results Discussion
Methods
Conclusions
